跳至主要内容
临床试验/CTRI/2026/01/102287
CTRI/2026/01/102287尚未招募不适用

Assessing the effectiveness of Homoeopathic medicines Cimicifuga racemosa and Sanguinaria canadensis in the management of Perimenopausal Syndrome - A comparative Study

Dr Ananyaa A G1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年2月4日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
70
试验地点
1

研究概览

简要总结

NEED FOR THE STUDY

Menopause is defined as the period marked by the permanent cessation of the menstrual cycle, signifying the end of reproductive life in a woman. Diagnosis of menopause is

confirmed by 12 consecutive months of amenorrhea. The symptoms that crop up during this phase are due to loss of follicular ovarian activity and subsequent estrogen deficiency.Perimenopause, or the menopausal transition phase, is a period during which there is a decline in hormonal activity of the ovary, which results in anovulation and eventual

cessation of menstruation. It spans for 3 to 4 years before menopause and continues up to 1 year following menopause.Symptoms of perimenopausal syndrome include irregular menstrual cycles, hot flushes, night sweats, urogenital symptoms, sleep disorders, mood swings, low sexual drive, irritability and memory issues. The average age of natural menopause in India is around 47 years. Menopause is a crucial milestone in the life of every woman. Studies have shown that women experience physical well as psychological distress during the perimenopausal period, which affects their quality of life. Homoeopathic medicines are effective in the management of Menopausal and Perimenopausal disorders. Homoeopathic literature has mentioned that Cimicifuga racemosa has been indicated for complaints that arise during the menopausal period. Also, Cimicifuga racemosa has a marked action on ovarian and uterine disorders. Sanguinaria canadensis has been well indicated for menopausal complaints in various literature. Also, an observational study showed that Sanguinaria canadensis, Belladonna, Lachesis, Sulphur and Sepia were effective in the management of hot flushes during menopause. The full potential of these two remedies for perimenopausal conditions remains under-researched till date.

Hence, this study intended to validate and compare the efficacy of Sanguinaria canadensis and Cimicifuga racemosa in the management of Perimenopausal Syndrome.

RESEARCH QUESTION

Is there any significant difference in the effectiveness of Homoeopathic medicines Cimicifuga racemosa and Sanguinaria canadensis in the management of Perimenopausal

Syndrome?

NULL HYPOTHESIS H0

There may not be significant difference between Homoeopathic medicines Cimicifuga racemosa and Sanguinaria canadensis in the management of Perimenopausal Syndrome.

RESEARCH HYPOTHESIS H1

There may be significant difference between Homoeopathic medicines Cimicifuga. racemosa  and Sanguinaria canadensis in the management of Perimenopausal Syndrome.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 55.00 Year(s)(—)
性别
Female

入选标准

  • Subjects who are willing to participate as volunteers and who have signed the informed consent.
  • Women diagnosed with perimenopausal syndrome.
  • Women who are screened on the basis of Menopausal Rating Scale with a score 5 and above.
  • Women between the age of 40-55 years.

排除标准

  • Subject who had undergone artificial menopause by surgical or radiation therapy.
  • Subjects with any diagnosed systemic illness.

研究者

发起方
Dr Ananyaa A G
申办方类型
Other [Principal Investigator]
责任方
Principal Investigator
主要研究者

Dr Ananyaa A G

Government Homoeopathic Medical College and Hospital Bengaluru

研究点 (1)

Loading locations...

相似试验